FULLER GILBERT A 4
4 · USANA HEALTH SCIENCES INC · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
USANA (USNA) Director Gilbert A. Fuller Exercises RSUs (1,057)
What Happened
- Gilbert A. Fuller, a director of USANA Health Sciences (USNA), had 1,057 restricted stock units (RSUs) convert into 1,057 shares on April 23, 2026 (reported as a derivative exercise/conversion). The Form 4 also shows a simultaneous disposition of 1,057 shares at $0.00 (reported as a derivative disposition). The filing does not report any cash proceeds from the disposition (total value $0.00 reported).
Key Details
- Transaction date: 2026-04-23 (reported on Form 4 filed 2026-04-27).
- Acquired: 1,057 shares via exercise/conversion (derivative, listed as N/A price).
- Disposed: 1,057 shares (derivative) at $0.00.
- Shares owned after transaction: not reported in this filing.
- Footnotes: F1 — each RSU entitles the holder to one share; F2 — these RSUs vest 25% on 4 scheduled dates including April 23, 2026 (this transaction coincides with that vesting date).
- Filing timeliness: Form 4 was filed April 27, 2026 (within the typical two-business-day reporting window).
Context
- This pattern—RSUs converting to shares and an equal number shown as disposed at $0.00—is commonly seen when vested awards are settled (for example, to satisfy tax withholding or as a net-share settlement). The Form 4 here does not specify the reason for the $0.00 disposition.
- These transactions reflect routine award vesting/settlement and do not, by themselves, indicate the director’s view on the company’s stock.
Insider Transaction Report
Form 4
FULLER GILBERT A
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-04-23+1,057→ 1,057 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-04-23−1,057→ 0 total→ Common Stock (1,057 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- [F2]Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Signature
/s/ Joshua Foukas, Attorney-in-Fact|2026-04-27